{
    "eid": "2-s2.0-85064193969",
    "title": "Optimal level of hepatitis B surface antibody for prevention of recurrent hepatitis B following liver transplantation: A retrospective study",
    "cover-date": "2019-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "HBsAb level",
        "Hepatitis B",
        "Hepatitis B immunoglobulin",
        "Liver transplantation",
        "Nucleoside analog"
    ],
    "authors": [
        "P. Komolmit",
        "N. Srisoonthorn",
        "K. Thanapirom",
        "K. Poovorawan",
        "S. Treeprasertsuk"
    ],
    "citedby-count": 0,
    "ref-count": 30,
    "ref-list": [
        "Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: Review of disease progression",
        "Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy",
        "Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis",
        "Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)",
        "Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications",
        "Liver transplantation (2)",
        "Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation",
        "Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease",
        "Liver transplantation in European patients with the hepatitis B surface antigen",
        "Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization",
        "Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin",
        "An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy",
        "Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation",
        "Hepatitis B immunoglobulin and/or nucleos(t) ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review",
        "Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin",
        "Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation",
        "Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update",
        "Prophylaxis and treatment of recurrent hepatitis B after liver transplantation",
        "Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis",
        "Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on",
        "Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B",
        "Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: Long-term results",
        "Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation",
        "Low-dose hepatitis B immunoglobulin given \u201con demand\u201d in combination with lamivudine: A highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term followup after liver transplantation",
        "Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation",
        "Anti-hepatitis B surface immunoglobulin reduction in early postoperative period after liver transplantation in hepatitis B virus-positive patients",
        "Prevention and treatment of recurrent hepatitis B after liver transplantation",
        "Evolving experience of hepatitis B virus prophylaxis in liver transplantation",
        "Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation",
        "Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Liver Diseases",
        "Thai Red Cross Society",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University"
    ]
}